Program Description & Educational Objectives

In this activity, an expert in infectious diseases discusses the diagnosis and management of invasive fungal infections.

Upon completion of this activity, participants will be able to:

• Identify risk factors for invasive fungal infections and select appropriate methods for establishing early diagnosis
• Apply evidence-based guidelines for the management of candidemia and invasive candidiasis to clinical practice
• Select prophylaxis regimens against invasive fungal infections for high-risk patient populations based on recent clinical evidence

Target Audience

This activity has been designed to meet the educational needs of US-based infectious disease specialists, nurses, pharmacists, and other clinicians involved in the management of patients with invasive fungal infections.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: January 10, 2011 - January 09, 2013
Time to Complete PeerView inPractice: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Course Director and Interviewee

Peter G. Pappas, MD
Professor of Medicine, Division of Infectious Diseases
Tinsley Harrison Clinical Scholar, Department of Medicine
University of Alabama at Birmingham
Birmingham, Alabama

Peter G. Pappas, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Astellas Pharma US, Inc.; Merck & Co., Inc.; and Pfizer Inc.
Honoraria from Astellas Pharma US, Inc.; Merck & Co., Inc.; and Pfizer Inc.
Advisory Board for Astellas Pharma US, Inc.and Merck & Co., Inc.

Content Directors

Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education, Inc.

Kathryn B. Charalambous, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.

Annette Wiggins
PVI, PeerView Institute for Medical Education, Inc.

Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Case-Based CME
Purdue University College of Pharmacy designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Performance Improvement CME
Purdue University College of Pharmacy designates this educational activity for a maximum of 20.0 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

Purdue University Continuing Nursing Education (CNEP-09, 06/01/2011) is an approved provider of continuing nursing education by the Indiana State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity has been approved for 1.0 contact hour(s).

Pharmacists

Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-10-264-H01-P, 1.0 contact hours (0.1 CEUs).
Release Date: January 10, 2011 Expiration Date: January 09, 2013

This CME/CNE/CPE activity is jointly sponsored by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.

This activity is supported through an independent educational grant from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.